# Orthofix Medical Inc.: filings

OFIX · Nasdaq · CIK 884624 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 23

Pages: [Overview](/companies/ofix.md) · [Financials](/companies/ofix/financials.md) · [Filings](/companies/ofix/filings.md) · [Insiders](/companies/ofix/insiders.md)

## Reports and events: 365 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 537, 8-K 251, SC 13G/A 68, 3 59, 10-Q 53, DEFA14A 31, S-8 30, SC 13G 24, 425 19, 4/A 19, 10-K 18, UPLOAD 18, DEF 14A 17, DFAN14A 14, CORRESP 13, SD 13, SCHEDULE 13G/A 9, SCHEDULE 13D/A 7, 10-K/A 6, 144 6, PRE 14A 6, S-8 POS 6, 8-K/A 5, CT ORDER 5, 3/A 4, 5 4, DEFC14A 4, NT 10-Q 4, DEFR14A 3, EFFECT 3, SC 13D/A 3, 10-Q/A 2, 424B3 2, DFRN14A 2, NT 10-K 2, PREC14A 2, PRER14A 2, PRRN14A 2, S-4 2, S-4/A 2, SC 13D 2, ARS 1, NTN 10Q 1, POS AM 1, S-3ASR 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 11:06 ET | [10-Q](/filings/0001193125-26-333822.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333822 |
| 2026-08-05 | 11:03 ET | [8-K](/filings/0001193125-26-333817.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-333817 |
| 2026-07-02 | 20:00 ET | [8-K](/filings/0001193125-26-294445.md) | 7.01 Regulation FD disclosure | 0001193125-26-294445 |
| 2026-06-11 | 11:01 ET | [8-K](/filings/0001193125-26-266679.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-266679 |
| 2026-05-27 | 20:12 ET | [SCHEDULE 13D/A](/filings/0001214659-26-006790.md) | Ownership report, active investor, amended | 0001214659-26-006790 |
| 2026-05-21 | 12:00 ET | [8-K](/filings/0001193125-26-233429.md) | 7.01 Regulation FD disclosure | 0001193125-26-233429 |
| 2026-05-05 | 11:03 ET | [10-Q](/filings/0001193125-26-205003.md) | Quarterly report, period 2026-03-31 | 0001193125-26-205003 |
| 2026-05-05 | 11:02 ET | [8-K](/filings/0001193125-26-204999.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-204999 |
| 2026-04-29 | 20:20 ET | [DEF 14A](/filings/0001193125-26-191716.md) | Proxy statement, period 2026-04-29 | 0001193125-26-191716 |
| 2026-04-09 | 11:02 ET | [8-K](/filings/0001193125-26-148853.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-148853 |
| 2026-02-24 | 12:04 ET | [10-K](/filings/0001193125-26-065189.md) | Annual report, period 2025-12-31 | 0001193125-26-065189 |
| 2026-02-24 | 12:01 ET | [8-K](/filings/0001193125-26-065184.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-065184 |
| 2026-02-13 | 21:25 ET | [SCHEDULE 13D/A](/filings/0001214659-26-001727.md) | Ownership report, active investor, amended | 0001214659-26-001727 |
| 2025-11-04 | 14:01 ET | [10-Q](/filings/0001193125-25-263670.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263670 |
| 2025-11-04 | 12:02 ET | [8-K](/filings/0001193125-25-263529.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-263529 |
| 2025-10-21 | 20:17 ET | [SCHEDULE 13D/A](/filings/0001214659-25-015160.md) | Ownership report, active investor, amended | 0001214659-25-015160 |
| 2025-09-25 | 00:03 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014209.md) | Ownership report, active investor, amended | 0001214659-25-014209 |
| 2025-08-05 | 11:05 ET | [10-Q](/filings/0000950170-25-102384.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102384 |
| 2025-08-05 | 11:03 ET | [8-K](/filings/0000950170-25-102383.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-102383 |
| 2025-06-20 | 13:00 ET | [8-K](/filings/0000950170-25-088194.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088194 |
| 2025-05-08 | 22:30 ET | [SCHEDULE 13D/A](/filings/0000921895-25-001347.md) | Ownership report, active investor, amended | 0000921895-25-001347 |
| 2025-05-06 | 11:05 ET | [10-Q](/filings/0000950170-25-063956.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063956 |
| 2025-05-06 | 11:03 ET | [8-K](/filings/0000950170-25-063953.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-063953 |
| 2025-04-30 | 20:13 ET | [DEF 14A](/filings/0000950170-25-061062.md) | Proxy statement, period 2025-06-18 | 0000950170-25-061062 |
| 2025-04-11 | 18:49 ET | [SCHEDULE 13D/A](/filings/0001214659-25-005766.md) | Ownership report, active investor, amended | 0001214659-25-005766 |
| 2025-04-07 | 20:48 ET | [8-K](/filings/0000950170-25-051645.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0000950170-25-051645 |
| 2025-03-12 | 12:03 ET | [8-K](/filings/0000950170-25-037630.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-037630 |
| 2025-02-27 | 23:20 ET | [SCHEDULE 13D/A](/filings/0000921895-25-000640.md) | Ownership report, active investor, amended | 0000921895-25-000640 |
| 2025-02-25 | 12:08 ET | [10-K](/filings/0000950170-25-026066.md) | Annual report, period 2024-12-31 | 0000950170-25-026066 |
| 2025-02-25 | 12:03 ET | [8-K](/filings/0000950170-25-026062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-026062 |
| 2025-01-07 | 21:00 ET | [SCHEDULE 13D](/filings/0001214659-25-000281.md) | Ownership report, active investor | 0001214659-25-000281 |
| 2024-11-08 | 21:35 ET | [8-K](/filings/0000950170-24-124165.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-124165 |
| 2024-11-07 | 12:08 ET | [10-Q](/filings/0000950170-24-122782.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122782 |
| 2024-11-07 | 12:06 ET | [8-K](/filings/0000950170-24-122777.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122777 |
| 2024-08-06 | 11:08 ET | [10-Q](/filings/0000950170-24-091200.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091200 |
| 2024-08-06 | 11:06 ET | [8-K](/filings/0000950170-24-091199.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091199 |
| 2024-06-20 | 11:00 ET | [8-K](/filings/0000950170-24-075288.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-075288 |
| 2024-05-07 | 12:06 ET | [10-Q](/filings/0000950170-24-053966.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053966 |
| 2024-05-07 | 12:04 ET | [8-K](/filings/0000950170-24-053961.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-053961 |
| 2024-04-29 | 20:59 ET | [DEF 14A](/filings/0000950170-24-050013.md) | Proxy statement, period 2024-04-29 | 0000950170-24-050013 |
| 2024-04-22 | 21:00 ET | [SC 13D/A](/filings/0000921895-24-000933.md) | Ownership report, active investor, amended | 0000921895-24-000933 |
| 2024-04-22 | 22:58 ET | [8-K](/filings/0000950170-24-046161.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-046161 |
| 2024-04-12 | 20:30 ET | [8-K](/filings/0000950170-24-044082.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-044082 |
| 2024-03-05 | 21:06 ET | [10-K](/filings/0000950170-24-025877.md) | Annual report, period 2023-12-31 | 0000950170-24-025877 |
| 2024-03-05 | 21:05 ET | [8-K](/filings/0000950170-24-025867.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-025867 |
| 2024-01-17 | 22:08 ET | [8-K](/filings/0000950170-24-005068.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-005068 |
| 2024-01-09 | 22:28 ET | [8-K](/filings/0000950170-24-003420.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-003420 |
| 2024-01-08 | 21:06 ET | [8-K](/filings/0000950170-24-002924.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002924 |
| 2023-12-15 | 21:14 ET | [8-K](/filings/0000950170-23-070740.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-070740 |
| 2023-12-13 | 22:16 ET | [SC 13D/A](/filings/0000921895-23-002760.md) | Ownership report, active investor, amended | 0000921895-23-002760 |

Page 1 of 8. [Older](/companies/ofix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.